BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee A, Rajanayagam J, Abdel-Hady M. Chronic Hepatitis C Infection in Children: Current Treatment and New Therapies. J Clin Transl Hepatol 2015;3:36-41. [PMID: 26357633 DOI: 10.14218/JCTH.2014.00036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Taye BW. A Path to Ending Hepatitis C in Ethiopia: A Phased Public Health Approach to Achieve Micro-Elimination. Am J Trop Med Hyg 2019;101:963-72. [PMID: 31516107 DOI: 10.4269/ajtmh.19-0295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Tischoff I. Fehlbildungen und Lebererkrankungen im Kindesalter. Pathologie 2020. [DOI: 10.1007/978-3-642-04557-8_2] [Reference Citation Analysis]
3 Quintero J, Juampérez J, Julio E, Cabello V, Mercadal-hally M, Soler-palacín P, Segarra Ó, Rodrigo C. Ledipasvir/sofosbuvir combination for chronic hepatitis C infection in children and adolescents. Anales de Pediatría (English Edition) 2019;90:141-147. [DOI: 10.1016/j.anpede.2018.07.004] [Reference Citation Analysis]
4 Tovo PA, Bezzio S, Gabiano C. Fetal Infections: Rubella, HIV, HCV, HBV, and Human Parvovirus B19. Neonatology 2018. [DOI: 10.1007/978-3-319-29489-6_251] [Reference Citation Analysis]
5 Tovo P, Bezzio S, Gabiano C. Fetal Infections: Rubella, HIV, HCV, HBV, and Human Parovirus B19. Neonatology 2017. [DOI: 10.1007/978-3-319-18159-2_251-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Siew SM, Kelly DA. Evaluation of jaundice in children beyond the neonatal period. Paediatrics and Child Health 2016;26:451-458. [DOI: 10.1016/j.paed.2016.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]